FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3027878000> ?p ?o ?g. }

• W3027878000 endingPage "879" @default.
• W3027878000 startingPage "871" @default.
• W3027878000 abstract "Intensity modulated proton beam radiation therapy (IMPT) has a clinically significant dosimetric advantage over intensity modulated photon radiation therapy (IMRT) for the treatment of patients with esophageal cancer, particularly for sparing the heart and lungs. We compared acute radiation therapy-related toxicities and short-term clinical outcomes of patients with esophageal cancer who received treatment with IMPT or IMRT.We retrospectively reviewed the electronic health records of consecutive adult patients with esophageal cancer who underwent concurrent chemoradiotherapy with IMPT or IMRT in the definitive or neoadjuvant setting from January 1, 2014, through June 30, 2018, with additional follow-up data collected through January 31, 2019. Treatment-related toxicities were evaluated per the Common Terminology Criteria for Adverse Events, version 4. Survival outcomes were estimated with the Kaplan-Meier method.A total of 64 patients (32 per group) were included (median follow-up time: 10 months for IMPT patients vs 14 months for IMRT patients). The most common radiation therapy regimen was 45 Gy in 25 fractions, and 80% of patients received a simultaneous integrated boost to a median cumulative dose of 50 Gy. Similar numbers of IMPT patients (n = 15; 47%) and IMRT patients (n = 18; 56%) underwent surgery (P = .07), with no difference in pathologic complete response rates (IMPT: n = 5; 33% vs IMRT: n = 7; 39%; P = .14). At 1 year, the clinical outcomes also were similar for IMPT and IMRT patients, respectively. Local control was 92% versus 84% (P = .87), locoregional control 92% versus 80% (P = .76), distant metastasis-free survival 87% versus 65% (P = .08), progression-free survival 71% versus 45% (P = .15), and overall survival 74% versus 71% (P = .62). The rate of acute treatment-related grade 3 toxicity was similar between the groups (P = .71).In our early experience, IMPT is a safe and effective treatment when administered as part of definitive or trimodality therapy. Longer follow-up is required to evaluate the effectiveness of IMPT." @default.
• W3027878000 created "2020-05-29" @default.
• W3027878000 creator A5002341560 @default.
• W3027878000 creator A5011672296 @default.
• W3027878000 creator A5011875259 @default.
• W3027878000 creator A5025580085 @default.
• W3027878000 creator A5028453964 @default.
• W3027878000 creator A5032470889 @default.
• W3027878000 creator A5032959560 @default.
• W3027878000 creator A5033395766 @default.
• W3027878000 creator A5039114910 @default.
• W3027878000 creator A5039358235 @default.
• W3027878000 creator A5046778428 @default.
• W3027878000 creator A5050766065 @default.
• W3027878000 creator A5064791048 @default.
• W3027878000 creator A5071037763 @default.
• W3027878000 creator A5089819634 @default.
• W3027878000 creator A5091820165 @default.
• W3027878000 date "2020-09-01" @default.
• W3027878000 modified "2023-09-23" @default.
• W3027878000 title "Acute Toxicities and Short-Term Patient Outcomes After Intensity-Modulated Proton Beam Radiation Therapy or Intensity-Modulated Photon Radiation Therapy for Esophageal Carcinoma: A Mayo Clinic Experience" @default.
• W3027878000 cites W2011163287 @default.
• W3027878000 cites W2026327854 @default.
• W3027878000 cites W2050690352 @default.
• W3027878000 cites W2051618879 @default.
• W3027878000 cites W2112455219 @default.
• W3027878000 cites W2145155701 @default.
• W3027878000 cites W2150993402 @default.
• W3027878000 cites W2154444715 @default.
• W3027878000 cites W2161395451 @default.
• W3027878000 cites W2232377395 @default.
• W3027878000 cites W2267955793 @default.
• W3027878000 cites W2333908381 @default.
• W3027878000 cites W2490017558 @default.
• W3027878000 cites W2508273416 @default.
• W3027878000 cites W2621240220 @default.
• W3027878000 cites W2624994933 @default.
• W3027878000 cites W2725572687 @default.
• W3027878000 cites W2754900050 @default.
• W3027878000 cites W2781525129 @default.
• W3027878000 cites W2896396926 @default.
• W3027878000 cites W2897855655 @default.
• W3027878000 cites W2945552838 @default.
• W3027878000 cites W2950180641 @default.
• W3027878000 cites W3012051758 @default.
• W3027878000 doi "https://doi.org/10.1016/j.adro.2020.04.026" @default.
• W3027878000 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7557123" @default.
• W3027878000 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33083649" @default.
• W3027878000 hasPublicationYear "2020" @default.
• W3027878000 type Work @default.
• W3027878000 sameAs 3027878000 @default.
• W3027878000 citedByCount "18" @default.
• W3027878000 countsByYear W30278780002020 @default.
• W3027878000 countsByYear W30278780002021 @default.
• W3027878000 countsByYear W30278780002022 @default.
• W3027878000 countsByYear W30278780002023 @default.
• W3027878000 crossrefType "journal-article" @default.
• W3027878000 hasAuthorship W3027878000A5002341560 @default.
• W3027878000 hasAuthorship W3027878000A5011672296 @default.
• W3027878000 hasAuthorship W3027878000A5011875259 @default.
• W3027878000 hasAuthorship W3027878000A5025580085 @default.
• W3027878000 hasAuthorship W3027878000A5028453964 @default.
• W3027878000 hasAuthorship W3027878000A5032470889 @default.
• W3027878000 hasAuthorship W3027878000A5032959560 @default.
• W3027878000 hasAuthorship W3027878000A5033395766 @default.
• W3027878000 hasAuthorship W3027878000A5039114910 @default.
• W3027878000 hasAuthorship W3027878000A5039358235 @default.
• W3027878000 hasAuthorship W3027878000A5046778428 @default.
• W3027878000 hasAuthorship W3027878000A5050766065 @default.
• W3027878000 hasAuthorship W3027878000A5064791048 @default.
• W3027878000 hasAuthorship W3027878000A5071037763 @default.
• W3027878000 hasAuthorship W3027878000A5089819634 @default.
• W3027878000 hasAuthorship W3027878000A5091820165 @default.
• W3027878000 hasBestOaLocation W30278780001 @default.
• W3027878000 hasConcept C121608353 @default.
• W3027878000 hasConcept C126322002 @default.
• W3027878000 hasConcept C126838900 @default.
• W3027878000 hasConcept C2777793932 @default.
• W3027878000 hasConcept C2778424827 @default.
• W3027878000 hasConcept C2779244869 @default.
• W3027878000 hasConcept C2779742542 @default.
• W3027878000 hasConcept C2989005 @default.
• W3027878000 hasConcept C509974204 @default.
• W3027878000 hasConcept C71924100 @default.
• W3027878000 hasConceptScore W3027878000C121608353 @default.
• W3027878000 hasConceptScore W3027878000C126322002 @default.
• W3027878000 hasConceptScore W3027878000C126838900 @default.
• W3027878000 hasConceptScore W3027878000C2777793932 @default.
• W3027878000 hasConceptScore W3027878000C2778424827 @default.
• W3027878000 hasConceptScore W3027878000C2779244869 @default.
• W3027878000 hasConceptScore W3027878000C2779742542 @default.
• W3027878000 hasConceptScore W3027878000C2989005 @default.
• W3027878000 hasConceptScore W3027878000C509974204 @default.
• W3027878000 hasConceptScore W3027878000C71924100 @default.
• W3027878000 hasIssue "5" @default.
• W3027878000 hasLocation W30278780001 @default.
• W3027878000 hasLocation W30278780002 @default.
• W3027878000 hasLocation W30278780003 @default.

• next